US Department of Defense contributions to malaria surveillance

Saunders, David; Duplessis, Christopher; Lescano, Andrés G.; Andagalu, Ben; Thomas, Alaina; Fukuda, Mark M.; Cummings, James F.

doi:10.1016/s1473-3099(13)70065-3

Cited by 2 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The current malaria treatment policy in Ghana and many endemic countries discourages monotherapy and recommends ACT because of its effectiveness in curing malaria. This current research points to the fact that continuous monotherapy to treat malaria could risk the development of resistant to malaria parasites in Africa, as is emerging in Asia [26-29]. …”

Section: Discussionmentioning

confidence: 99%

The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana

Aborah

Akweongo

Adjuik

et al. 2013

Malar J

View full text Add to dashboard Cite

BackgroundThe use of non-prescribed anti-malarial drugs can lead to treatment failure and development of drug-resistant parasites. This study investigated the use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga Municipality of northern Ghana.MethodsThis was a cross-sectional survey of a random sample of 392 adults and children with episodes of malaria in the last four weeks prior to the study.ResultsMajority of survey respondents 96.9% (380) knew the symptoms of malaria, 75% (294) knew the causes of malaria and 93.1% (365) were aware of mode of transmission of malaria. The use of non-prescribed anti-malarial drugs was 16.8% (95% CI: 13.3-21.0) among the respondents. About 56% (95% CI: 43.3-68.3) of the respondents who took non-prescribed anti-malaria drugs took non-artemisinin-based combination therapy (chloroquine, artemether, amodiaquine and sulphadoxine-pyrimethamine). Respondents above five years of age were more likely to use non-prescribed anti-malarial drugs than those below five years of age [P < 0.001]; respondents who knew the right source of malaria treatment were less likely to use non-prescribed anti-malarial drugs than those who did not [P = 0.002]. Respondents using non-prescribed anti-malarials were influenced by people around them who used non-prescribed anti-malarials. Thus, these respondents were more likely to use non-prescribed anti-malarials than those who were not influenced [P = 0.004].ConclusionsRespondents’ knowledge of malaria treatment and the influence of people using non-prescribed anti-malarials are factors affecting use of non-prescribed anti-malarials. The study concludes that there is high use of non-prescribed anti-malarial drugs in the municipality and most of the non-prescribed anti-malarias were non-artemisinin-based combination therapy. The study recommends education of the general public and chemical sellers to reduce the use of non-prescribe anti-malaria drugs.

show abstract

Section: Discussionmentioning

confidence: 99%